Blood pressure, proteinuria, and phosphate as risk factors for progressive kidney disease: a hypothesis

Am J Kidney Dis. 2013 Nov;62(5):984-92. doi: 10.1053/j.ajkd.2013.02.379. Epub 2013 May 10.

Abstract

Chronic kidney disease (CKD) affects approximately 500 million people worldwide and is increasingly common in both industrialized and emerging countries. Although the mechanisms underlying the inexorable progression of CKD are incompletely defined, recent discoveries may pave the way to a more comprehensive understanding of the pathophysiology of CKD progression and the development of new therapeutic strategies. In particular, there is accumulating evidence indicating a key role for the complex and yet incompletely understood system of divalent cation regulation, which includes phosphate metabolism and the recently discovered fibroblast growth factor 23 (FGF-23)/klotho system, which seems inextricably associated with vitamin D deficiency. The aim of this review is to discuss the links between high blood pressure, proteinuria, phosphate levels, and CKD progression and explore new therapeutic strategies to win the fight against CKD.

Keywords: Chronic kidney disease; blood pressure; phosphate; proteinuria; vitamin D deficiency.

Publication types

  • Review

MeSH terms

  • Blood Pressure / physiology
  • Disease Progression*
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors / physiology
  • Glucuronidase / physiology
  • Humans
  • Hypertension / complications*
  • Hypertension / physiopathology
  • Kidney Diseases / epidemiology*
  • Kidney Diseases / metabolism
  • Kidney Diseases / physiopathology
  • Klotho Proteins
  • Phosphorus / metabolism*
  • Proteinuria / complications*
  • Proteinuria / physiopathology
  • Risk Factors
  • Vitamin D Deficiency / complications
  • Vitamin D Deficiency / physiopathology

Substances

  • FGF23 protein, human
  • Phosphorus
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Glucuronidase
  • Klotho Proteins